Hjem › Hjertesvikt › Minnesota › Minneapolis
Kliniske studier for Hjertesvikt i Minneapolis, MN
21 studier for Hjertesvikt søker deltakere på steder i og rundt Minneapolis (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
ELEVATE-HFpEF Clinical Study
Rekrutterer
- M Health Fairview University of Minnesota Medical Center - East Bank, Minneapolis
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
RekruttererFase 3
- Minneapolis VA Health Care System, Minneapolis
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
RekruttererFase 3
- Minneapolis VA Health Care System, Minneapolis
Alleviant ALLAY-HFrEF Study
Rekrutterer
- Minneapolis Heart Institute Foundation, Minneapolis
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
RekruttererFase 3
- University of Minnesota, Minneapolis
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
RekruttererFase 3
- Research Site, Minneapolis
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
RekruttererFase 3
- Minneapolis, MN Investigative Site CON-10035, Minneapolis
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
RekruttererFase 3
- Minneapolis, MN Investigative Site 10091, Minneapolis
- Minneapolis, MN Investigative Site 10035, Minneapolis
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Rekrutterer
- Abbott Northwestern Hospital, Minneapolis
- University of Minnesota, Minneapolis
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
RekruttererObservasjonsstudie
- Minneapolis, Minneapolis
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
RekruttererObservasjonsstudie
- Minneapolis Heart Institute Foundation, Minneapolis
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
RekruttererFase 3
- Tenax Investigational Site, Minneapolis
Alleviant ALLAY-HF Study
Rekrutterer
- Minneapolis Heart Institute Foundation, Minneapolis
CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)
Rekrutterer
- Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
Assessment of CCM in HF With Higher Ejection Fraction
Rekrutterer
- Minneapolis Heart Institute at Abbott Northwestern Hospital, Minneapolis
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
RekruttererFase 3
- Minneapolis, MN Investigative Site FIN-10035, Minneapolis
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Rekrutterer
- University of Minnesota, Minneapolis
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Rekrutterer
- Minneapolis Heart Institute, Minneapolis
CCM OPEN HF Registry
RekruttererObservasjonsstudie
- Minneapolis Heart Institute Research Foundation, Minneapolis
Secondary Mitral Regurgitation Treatment With MitraClip and Assessment by Cardiac Magnetic Resonance
RekruttererObservasjonsstudie
- Minneapolis Heart Institute Foundation, Minneapolis
HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry
RekruttererObservasjonsstudie
- Minneapolis Heart Institute Foundation/ Allina Health, Minneapolis
Hjertesvikt-studier i andre byer
- New York City, NY51 studier
- Boston, MA44 studier
- Dallas, TX42 studier
- Houston, TX36 studier
- Cleveland, OH33 studier
- Chicago, IL31 studier
- Philadelphia, PA31 studier
- San Francisco, CA29 studier
- St. Louis, MO26 studier
- Durham, NC26 studier
- Kansas City, MO25 studier
- Atlanta, GA25 studier
Andre studier i Minneapolis
- Brystkreft27 studier
- Ikke-småcellet lungekreft26 studier
- Eggstokkreft24 studier
- Prostatakreft23 studier
- Kreft (alle typer)22 studier
- Lungekreft20 studier
- Akut myelogen leukemi20 studier
- Kolorektal kreft19 studier
- Endometriekreft18 studier
- Parkinsons sykdom17 studier
- Kardiovaskulær sykdom15 studier
- Koronararteriesykdom13 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.